GMS Ventures & Investments - 17 Jan 2025 SCHEDULE 13D/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: GMS Ventures & Investments
Reporting Manager: GMS VENTURES & INVESTMENTS
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 32,966,881 shares
Disclosed Ownership: 12,725,216 shares
Ownership: 39%
Form type: SCHEDULE 13D/A
Filing time: 22 Jan 2025, 16:17:28 UTC
Date of event: 17 Jan 2025
Next filing: 12 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GMS VENTURES & INVESTMENTS	39%	12,725,216	0	12,725,216	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon	0001804598
SUKHTIAN GHIATH M.	39%	12,725,216	0	12,725,216	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon	0001717441